Early research (Phase 1)Study completedNCT01723020
What this trial is testing
Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma
Who this might be right for
Advanced MalignancyAdvanced Solid TumorsCancer+5 more
Kartos Therapeutics, Inc. 107